Data / Form D filings / Alume Biosciences Inc
Alume Biosciences Inc: Form D filings
Alume Biosciences Inc, a biotechnology company in La Jolla, CA, filed 12 Form D notices with the SEC between 2019 and 2026. The latest, on May 8, 2026, reports $2.2 million sold of a $8 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2223 AVENIDA DE LA PLAYA SUITE 205, La Jolla, CA, 92037
- Phone
- (858) 254-7116
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1782348
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 8, 2026 | Amendment | $8,000,000 | $2,160,000 | $5,840,000 | 4 | Mar 24, 2026 | sec.gov |
| Apr 6, 2026 | New notice | $8,000,000 | $110,000 | $7,890,000 | 2 | Mar 24, 2026 | sec.gov |
| Feb 19, 2026 | Amendment | $23,499,998 | $6,853,305 | $16,646,693 | 92 | Oct 30, 2025 | sec.gov |
| Jan 30, 2026 | Amendment | $23,499,998 | $5,967,305 | $17,532,693 | 77 | Oct 30, 2025 | sec.gov |
| Dec 31, 2025 | Amendment | $23,499,998 | $5,316,105 | $18,183,893 | 62 | Oct 30, 2025 | sec.gov |
| Nov 12, 2025 | Amendment | $23,499,998 | $3,611,116 | $19,888,882 | 46 | Oct 30, 2025 | sec.gov |
| Oct 31, 2025 | New notice | $23,499,998 | $3,055,500 | $20,444,498 | 37 | Oct 30, 2025 | sec.gov |
| Jan 9, 2023 | New notice | $45,024,930 | $12,759,950 | $32,264,980 | 43 | Dec 28, 2022 | sec.gov |
| Sep 21, 2022 | Amendment | $5,225,000 | $4,000,000 | $1,225,000 | 26 | Apr 1, 2022 | sec.gov |
| Apr 15, 2022 | New notice | $5,000,000 | $3,050,000 | $1,950,000 | 23 | Apr 1, 2022 | sec.gov |
| Aug 26, 2020 | New notice | $4,000,000 | $4,000,000 | 34 | Aug 21, 2020 | sec.gov | |
| Jul 11, 2019 | New notice | $8,571,156 | $5,772,023 | $2,799,133 | 40 | Jun 28, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Quyen Nguyen | Executive Officer, Director | |
| Brett Berman | Executive Officer, Director | |
| Dan Bradbury | Director | |
| Kim Kamdar | Director | |
| Magda Marquet | Director | |
| Jean-Pierre Millon | Director | |
| James Schmidt | Executive Officer | |
| Kaveri Parker | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of May 4, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Alume Biosciences Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.